CFTR and cystic fibrosis: The treatment of human cerebrovascular cells, placental cells, and bronchial epithelial cystic fibrosis cells, corrected or uncorrected for CFTR, by chloroquine (50 nM × 24 h), significantly reduced the ARSB activity, protein, and mRNA [44].